FDA Holds Up Vaccine, Bexsero, That Could Stifle Meningitis Outbreaks

Our government red tape will make sure that we no longer remain a super power in the world.
Check it out:

Meningitis is an infection of the brain, spinal cord, or other nerve tissue. The disease is usually traced to one of five different strains of the meningococcus bacteria, which can cripple or kill; recently, worldwide, as many as 4,000 people have died each year of the disease.

Only a small number of those deaths occurred in the United States, but a fifth of all those who contract the malady end up suffering from some kind of permanent damage.

For example, there’s Aaron Loy, a student and lacrosse player at the University of California at Santa Barbara (UCSB), whose feet had to be amputated after his bout with meningitis. Indeed, the young man could face other challenges, too, for the rest of his life. As Loy’s parents wrote of their son on CaringBridge.com in December, “With his intubation out, his speech, strength and awareness improve incrementally each day. These ‘baby steps’ are actually ‘HUGE STEPS’ recognizing the severity of where he was.”

In addition, meningitis outbreaks have also occurred at Princeton University and now, also, Northern Arizona University.

Interestingly, there’s a vaccine for meningitis, Bexsero, which has been approved in Europe, Canada, and Australia – but not in the US. Why not in the US? Because our Food and Drug Administration just doesn’t operate that way. The FDA bureaucrats work according to their risk-averse, Naderite, leave-at-five-pm timetable. So no need to worry much about ordinary people and their need for medicine.



Sign up for our daily email and get the stories everyone is talking about.


Previous post

Boehner on BridgeGate: 'Not Going Away'

Next post

Homeland Security Chief Jeh Johnson: Illegals Have ‘Earned the Right to be Citizens’

Join the conversation!

We have no tolerance for comments containing violence, racism, vulgarity, profanity, all caps, or discourteous behavior. Thank you for partnering with us to maintain a courteous and useful public environment where we can engage in reasonable discourse.